Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Inhibition of the adenosine A2a receptor modulates expression of T cell coinhibitory receptors and improves effector function for enhanced checkpoint blockade and ACT in murine cancer models
Robert D. Leone, Im-Meng Sun, Min Hee Oh, et al.
Cancer Immunology Immunotherapy (2018) Vol. 67, Iss. 8, pp. 1271-1284
Closed Access | Times Cited: 159

Showing 1-25 of 159 citing articles:

Metabolism of immune cells in cancer
Robert D. Leone, Jonathan D. Powell
Nature reviews. Cancer (2020) Vol. 20, Iss. 9, pp. 516-531
Open Access | Times Cited: 609
The adenosine pathway in immuno-oncology
Bertrand Allard, David Allard, Laurence Buisseret, et al.
Nature Reviews Clinical Oncology (2020) Vol. 17, Iss. 10, pp. 611-629
Closed Access | Times Cited: 405
Targeting Adenosine in Cancer Immunotherapy to Enhance T-Cell Function
Selena Viganó, Dimitrios Alatzoglou, Melita Irving, et al.
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 355
Immunotherapy: Reshape the Tumor Immune Microenvironment
Bingzhe LV, Yunpeng Wang, Dongjiang Ma, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 281
Adenosine 2A Receptor Blockade as an Immunotherapy for Treatment-Refractory Renal Cell Cancer
Lawrence Fong, Andrew Hotson, John D. Powderly, et al.
Cancer Discovery (2019) Vol. 10, Iss. 1, pp. 40-53
Open Access | Times Cited: 274
Targeting CD39 in cancer
Achim K. Moesta, Xian-Yang Li, Mark J. Smyth
Nature reviews. Immunology (2020) Vol. 20, Iss. 12, pp. 739-755
Closed Access | Times Cited: 254
Next-generation immuno-oncology agents: current momentum shifts in cancer immunotherapy
Chong-xian Pan, Hongtao Liu, Elizabeth Robins, et al.
Journal of Hematology & Oncology (2020) Vol. 13, Iss. 1
Open Access | Times Cited: 215
Hypoxia as a driver of resistance to immunotherapy
Joanna Kopecka, Iris C. Salaroglio, Elisabeth Pérez-Ruíz, et al.
Drug Resistance Updates (2021) Vol. 59, pp. 100787-100787
Open Access | Times Cited: 178
Targeting Adenosine Receptor Signaling in Cancer Immunotherapy
Kevin Sek, Christina Mølck, Gregory D. Stewart, et al.
International Journal of Molecular Sciences (2018) Vol. 19, Iss. 12, pp. 3837-3837
Open Access | Times Cited: 170
Adenosine mediates functional and metabolic suppression of peripheral and tumor-infiltrating CD8+ T cells
Béatris Mastelic-Gavillet, Blanca Navarro Rodrigo, Laure Décombaz, et al.
Journal for ImmunoTherapy of Cancer (2019) Vol. 7, Iss. 1
Open Access | Times Cited: 170
ATP and cancer immunosurveillance
Oliver Kepp, Lucillia Bezu, Takahiro Yamazaki, et al.
The EMBO Journal (2021) Vol. 40, Iss. 13
Open Access | Times Cited: 160
CD39/CD73/A2AR pathway and cancer immunotherapy
Chenglai Xia, Shuanghong Yin, Kenneth K.W. To, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 154
How to turn up the heat on the cold immune microenvironment of metastatic prostate cancer
Jacob Stultz, Lawrence Fong
Prostate Cancer and Prostatic Diseases (2021) Vol. 24, Iss. 3, pp. 697-717
Open Access | Times Cited: 152
CRISPR/Cas9 mediated deletion of the adenosine A2A receptor enhances CAR T cell efficacy
Lauren Giuffrida, Kevin Sek, Melissa A. Henderson, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 143
The hallmarks of cancer immune evasion
Claudia Galassi, Timothy A. Chan, Ilio Vitale, et al.
Cancer Cell (2024) Vol. 42, Iss. 11, pp. 1825-1863
Closed Access | Times Cited: 85
Next steps for clinical translation of adenosine pathway inhibition in cancer immunotherapy
Ryan C. Augustin, Robert D. Leone, Aung Naing, et al.
Journal for ImmunoTherapy of Cancer (2022) Vol. 10, Iss. 2, pp. e004089-e004089
Open Access | Times Cited: 82
Inosine induces stemness features in CAR-T cells and enhances potency
Dorota D. Klysz, Carley Fowler, Meena Malipatlolla, et al.
Cancer Cell (2024) Vol. 42, Iss. 2, pp. 266-282.e8
Open Access | Times Cited: 52
CD73/adenosine dynamics in treatment-induced pneumonitis: balancing efficacy with risks of adverse events in combined radio-immunotherapies
Lena Gockeln, Florian Wirsdörfer, Verena Jendrossek
Frontiers in Cell and Developmental Biology (2025) Vol. 12
Open Access | Times Cited: 3
Exploring the role of metabolic pathways in TNBC immunotherapy: insights from single-cell and spatial transcriptomics
Shiliang Chen, Yingxue Fei, Xiaoli Cai, et al.
Frontiers in Endocrinology (2025) Vol. 15
Open Access | Times Cited: 2
Realizing the Clinical Potential of Immunogenic Cell Death in Cancer Chemotherapy and Radiotherapy
Bernardo L. Rapoport, Ronald Anderson
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 4, pp. 959-959
Open Access | Times Cited: 132
Type I interferon suppresses tumor growth through activating the STAT3-granzyme B pathway in tumor-infiltrating cytotoxic T lymphocytes
Chunwan Lu, John D. Klement, Mohammed L. Ibrahim, et al.
Journal for ImmunoTherapy of Cancer (2019) Vol. 7, Iss. 1
Open Access | Times Cited: 116
The Next Generation of Immunotherapy for Cancer: Small Molecules Could Make Big Waves
William G. Kerr, John D. Chisholm
The Journal of Immunology (2018) Vol. 202, Iss. 1, pp. 11-19
Open Access | Times Cited: 106
Current Understanding of the Mechanisms Underlying Immune Evasion From PD-1/PD-L1 Immune Checkpoint Blockade in Head and Neck Cancer
Victor C. Kok
Frontiers in Oncology (2020) Vol. 10
Open Access | Times Cited: 92
Targeting the Immunomodulatory CD73/Adenosine System to Improve the Therapeutic Gain of Radiotherapy
Simone de Leve, Florian Wirsdörfer, Verena Jendrossek
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 81
CD73's Potential as an Immunotherapy Target in Gastrointestinal Cancers
Jerry B. Harvey, Luan Phan, Oscar E. Villarreal, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 72
Page 1 - Next Page

Scroll to top